USANA Health Sciences Inc (USNA)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 6.00 | 6.24 | 6.16 | 5.99 | 6.83 | 7.00 | 5.65 | 5.01 | 5.07 | 5.25 | 4.96 | 4.14 | 3.10 | 2.53 | 2.73 | 3.10 | 2.72 | 2.49 | 2.20 | 2.28 |
| Receivables turnover | 128.21 | — | — | — | 138.90 | — | — | — | 166.15 | — | — | — | 153.34 | — | — | — | 121.08 | — | — | — |
| Payables turnover | 36.60 | 40.23 | 41.17 | 36.75 | 41.44 | 45.45 | 46.76 | 43.48 | 36.88 | 36.88 | 33.81 | 30.36 | 15.37 | 13.93 | 17.26 | 15.87 | 14.97 | 22.04 | 16.57 | 16.86 |
| Working capital turnover | 3.09 | 3.35 | 3.47 | 3.68 | 4.16 | 4.84 | 5.19 | 5.61 | 5.82 | 5.87 | 5.51 | 5.32 | 4.42 | 4.86 | 5.71 | 6.50 | 5.49 | 7.10 | 5.11 | 4.87 |
USANA Health Sciences Inc's activity ratios provide valuable insights into the efficiency of the company's operations over the given periods.
1. Inventory turnover: The trend in inventory turnover ratio shows a general fluctuation, with a peak at 7.00 in Sep 2022 and a low of 2.20 in Mar 2019. The company has managed to maintain a moderate inventory turnover ratio, indicating efficient management of inventory levels.
2. Receivables turnover: The receivables turnover ratio fluctuates significantly, with values ranging from a high of 166.15 in Dec 2021 to a low of 121.08 in Dec 2019. The company has shown efficient collection of receivables, with higher turnover ratios generally indicating faster collection cycles.
3. Payables turnover: The payables turnover ratio has shown a decreasing trend over time, with the ratio declining from a peak of 46.76 in Jun 2022 to a low of 13.93 in Sep 2020. A decreasing payables turnover ratio may imply a longer payment cycle for the company.
4. Working capital turnover: The working capital turnover ratio has shown some variability but generally remained above 3.00, indicating that the company is effectively utilizing its working capital to generate revenues. The ratio peaked at 7.10 in Sep 2019 and trended downwards but remained relatively stable.
In conclusion, USANA Health Sciences Inc has maintained relatively stable inventory turnover, efficient receivables collection, and effective working capital utilization. However, the decreasing trend in payables turnover may warrant further investigation into the company's payment practices and relationships with suppliers.
Average number of days
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 60.86 | 58.47 | 59.24 | 60.94 | 53.48 | 52.14 | 64.57 | 72.82 | 72.03 | 69.56 | 73.58 | 88.17 | 117.78 | 144.55 | 133.91 | 117.80 | 134.13 | 146.52 | 166.03 | 160.01 |
| Days of sales outstanding (DSO) | days | 2.85 | — | — | — | 2.63 | — | — | — | 2.20 | — | — | — | 2.38 | — | — | — | 3.01 | — | — | — |
| Number of days of payables | days | 9.97 | 9.07 | 8.87 | 9.93 | 8.81 | 8.03 | 7.81 | 8.39 | 9.90 | 9.90 | 10.80 | 12.02 | 23.75 | 26.21 | 21.15 | 23.00 | 24.38 | 16.56 | 22.03 | 21.65 |
Based on the data provided, we can analyze the activity ratios of USANA Health Sciences Inc as follows:
1. Days of Inventory on Hand (DOH):
- The DOH for USANA Health Sciences Inc has been fluctuating over the periods analyzed, ranging from a low of 52.14 days to a high of 166.03 days.
- A lower DOH indicates that the company is selling inventory more quickly, while a higher DOH suggests that the inventory turnover is slower.
- The most recent DOH figure of 60.86 days as of December 31, 2023, shows a moderate level of inventory turnover compared to previous periods.
2. Days of Sales Outstanding (DSO):
- The DSO metric is crucial for understanding how quickly the company collects its accounts receivable.
- Data for DSO is incomplete for some periods, indicating that not all information is available for analysis.
- The available DSO figures show a range from 2.20 days to 3.01 days, which suggests that the company generally collects payments from customers swiftly.
3. Number of Days of Payables:
- The number of days of payables indicates how quickly the company pays its suppliers.
- The trend for this metric has varied over time, with figures ranging from 7.81 days to 26.21 days.
- A lower number of days of payables suggests that the company is paying its suppliers more quickly, while a higher number indicates a longer payment cycle.
In conclusion, USANA Health Sciences Inc's activity ratios reflect its efficiency in managing inventory, collecting receivables, and paying suppliers. The company appears to have a moderate level of inventory turnover, efficient accounts receivable collection, and a varying but generally reasonable payment cycle to suppliers. Monitoring these activity ratios can provide insights into the company's operational effectiveness and liquidity management.
Long-term
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | 9.25 | 9.77 | 9.92 | 10.09 | 10.25 | 10.94 | 11.07 | 11.46 | 11.69 | 12.24 | 12.86 | 11.97 | 11.33 | 11.02 | 10.74 | 10.84 | 11.14 | 11.90 | 12.14 | 12.72 |
| Total asset turnover | 1.46 | 1.55 | 1.58 | 1.61 | 1.68 | 1.87 | 1.94 | 2.02 | 2.06 | 2.13 | 2.13 | 2.02 | 1.78 | 1.90 | 2.06 | 2.23 | 2.05 | 2.35 | 2.11 | 2.12 |
USANA Health Sciences Inc's long-term activity ratios show an increasing trend in both fixed asset turnover and total asset turnover over the analyzed periods. The fixed asset turnover ratio has consistently been high, indicating the company efficiently generates sales revenue relative to its investment in fixed assets. This suggests effective utilization of fixed assets to generate sales.
Moreover, the total asset turnover ratio has also shown an upward trend, reflecting the company's ability to generate sales revenue relative to its total assets. This indicates efficient management of all assets, including fixed and current assets, to generate sales.
Overall, the increasing trend in both ratios signifies USANA Health Sciences Inc's effective asset utilization and management in generating sales revenue over the analyzed periods, which is a positive indicator of the company's operational efficiency.